BIOMAT Database Logo BIOMAT Database Logo

Fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli isolated from human faeces in Switzerland. 1991

H Adler-Mosca, and M Altwegg

UI MeSH Term Description Entries
D009643 Norfloxacin A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE. AM-0715,AM-715,MK-0366,MK-366,MK0366,MK366,Noroxin,AM 0715,AM 715,AM0715,MK 0366,MK 366
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013557 Switzerland A country in Europe. It is bordered by Austria, France, Italy, Liechtenstein, and Germany. The capital is Bern.
D016123 Campylobacter jejuni A species of bacteria that resemble small tightly coiled spirals. Its organisms are known to cause abortion in sheep and fever and enteritis in man and may be associated with enteric diseases of calves, lambs, and other animals. Campylobacter fetus subsp. jejuni,Vibrio hepaticus,Vibrio jejuni
D017000 Campylobacter coli A species of gram-negative, rod-shaped bacteria isolated from the intestinal tract of swine, poultry, and man. It may be pathogenic. Vibrio coli

Related Publications

H Adler-Mosca, and M Altwegg
Resistance to erythromycin in fluoroquinolone-resistant Campylobacter jejuni strains isolated from human faeces.
February 1995, The Journal of antimicrobial chemotherapy,
H Adler-Mosca, and M Altwegg
Fluoroquinolone resistance and gyrA mutations in Campylobacter jejuni and Campylobacter coli isolated from chicken in Egypt.
June 2018, Journal of global antimicrobial resistance,
H Adler-Mosca, and M Altwegg
Fitness cost of fluoroquinolone resistance in Campylobacter coli and Campylobacter jejuni.
June 2011, Microbial drug resistance (Larchmont, N.Y.),
H Adler-Mosca, and M Altwegg
Characterization of Campylobacter jejuni/coli-isolates from human faeces.
October 1984, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology,
H Adler-Mosca, and M Altwegg
Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland.
October 1991, Antimicrobial agents and chemotherapy,
H Adler-Mosca, and M Altwegg
Fluoroquinolone resistance detection in Campylobacter coli and Campylobacter jejuni by Luminex xMAP technology.
September 2010, Foodborne pathogens and disease,
H Adler-Mosca, and M Altwegg
Fluoroquinolone and macrolide resistance in Campylobacter jejuni isolated from broiler slaughterhouses in southern Brazil.
January 2016, Avian pathology : journal of the W.V.P.A,
H Adler-Mosca, and M Altwegg
Fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli from poultry and human samples assessed by PCR-restriction fragment length polymorphism assay.
January 2018, PloS one,
H Adler-Mosca, and M Altwegg
Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
August 2005, Antimicrobial agents and chemotherapy,
H Adler-Mosca, and M Altwegg
Efflux Pump Inhibitors, Alpha-Tocopherol and Aspirin: Role in Campylobacter jejuni and Campylobacter coli Fluoroquinolone Resistance.
March 2019, Microbial drug resistance (Larchmont, N.Y.),
Copied contents to your clipboard!